Table 2. Plasma measurements in the basal state and during euglycemic-hyperinsulinemic clamps.
| Control group (n) | Yacon group (n) | |
|---|---|---|
| BW (g) | 496.5±13.5 (16) | 502.4±7.1 (16) |
| Food consumption (gram per day) | 25.3±1.3 (16) | 26.4±1.7 (16) |
| Basal | ||
| Glucose (mg dl−1) | 184.1±4.1 (16) | 167.9±2.7* (16) |
| Insulin (ng ml−1) | 13.2±0.6 (16) | 10.4±0.4* (16) |
| HOMA-IR | 6.03±0.34 (16) | 4.30±0.19* (16) |
| Total cholesterol (mg dl−1) | 112.0±12.7 (6) | 101.0±15.0 (6) |
| Triglycerides (mg dl−1 | 253.7±58.2 (6) | 215.7±40.6 (6) |
| HDL-cholesterol (mg dl−1) | 47.2±4.8 (6) | 45.5±5.4 (6) |
| Adiponectin (μg ml−1) | 2.08±0.13 (6) | 2.35±0.17 (6) |
| Clamp | ||
| Ginf (mg kg−1 per minute) | 13.2±0.2 (8) | 14.8±0.4* (8) |
| Glucose (mg dl−1) | 151.7±1.1 (8) | 149.5 ±0.9 (8) |
Abbreviations: BW, Body weight; Ginf, glucose infusion rate; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment insulin resistance.
*: P<0.01